Real Impact Through Real Connections: Accelerating Obesity Drug Development with Direct-from-Patient Real-World Data
Time: 1:35 pm
day: Day Two
Details:
- Direct, ongoing relationships with individuals enable collection of real-world data that reflects lived experience capturing treatment use, behavior change, and symptom progression over time
- Interactive, longitudinal models support rapid subpopulation identification and phenotyping by integrating clinical, behavioral, and digital measures
- Recontactable individuals enable faster identification and enrollment of targeted subpopulations, while supporting longitudinal follow-up for responder analysis and postapproval evidence generation
